The NanoDis System provides formulation scientists with accurate release profiles of APIs using conventional dissolution apparatus in an automated, compliant manner. This functionality enables analysts to uncover the best nanoparticle formulation faster and get new drug formulations to market more quickly.
Easily transition from R&D to QC environments and achieve consistent, reliable dissolution results for nanoparticle-based formulations in an automated process while ensuring cGMP compliance.
Features:
Manufacturer Agilent Technologies | Available Worldwide
Be the first to review this product